| Upcoming events on HAEMONETICS CORPORATION |
|
| 02/02/21 | 06:00am | | Q3 2021 Earnings Release |
| 02/02/21 | 08:00am | | Q3 2021 Earnings Call |
| 05/11/21 | | FY 2021 Earnings Release (Projected) |
| 08/10/21 | | Q1 2022 Earnings Release (Projected) |
|
| Past events on HAEMONETICS CORPORATION |
|
| 12/13/20 | | AACC Scientific & Clinical Lab Expo |
| 12/07/20 | | Trauma Quality Improvement Program Scientific Meeting |
| 11/13/20 | | Jefferies Virtual London Healthcare Conference |
| 11/04/20 | 08:00am | | Interim 2021 Earnings Call |
|
| Upcoming sector events for HAEMONETICS CORPORATION |
|
|
| |
|
| Past sector events for HAEMONETICS CORPORATION |
|
|
|
|
|
| Annual results | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 (e) |
Sales
M $ |
Released
Forecast
Spread | 910
912
-0,20% | 886
877
1,0% | 904
898
0,66% | 968
968
-0,09% | 988
996
-0,74% |
855
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | 210
209
0,19% | 205
199
3,2% | 208
206
0,60% | 248
257
-3,5% | 307
324
-5,3% |
246
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | 120
127
-5,8% | 115
117
-0,95% | 131
135
-2,6% | 165
162
1,6% | 218
221
-1,2% |
161
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -53,5
-25,9
-106% | -27,5
50,9
-154% | 59,6
111
-46% | 73,6
83,7
-12% | 87,2
95,2
-8,5% |
109
|
Net income
M $ |
Released
Forecast
Spread | -55,6
-33,7
-65% | -26,3
39,8
-166% | 45,6
68,0
-33% | 55,0
52,6
4,7% | 76,5
84,2
-9,1% |
108
|
EPS
$ |
Released
Forecast
Spread | -1,09
-0,62
-75% | -0,51
0,79
-164% | 0,85
1,20
-29% | 1,04
1,17
-11% | 1,48
1,62
-8,8% |
2,03
| | Announcement Date | 05/02/2016 | 05/08/2017 | 05/08/2018 | 05/07/2019 | 05/05/2020 | |
|
|
|
| Quarterly results | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 (e) | 2021 Q4 (e) | 2022 Q1 (e) | 2022 Q2 (e) | 2022 Q3 (e) |
Sales
M $ |
Released
Forecast
Spread | 229
220
4,3% | 242
233
3,5% | 247
250
-1,1% | 249
251
-0,53% | 238
237
0,69% | 253
250
1,1% | 259
255
1,4% | 238
247
-3,3% | 196
198
-1,4% | 209
208
0,88% |
224
|
226
|
233
|
247
|
256
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | 64,2
49,4
30% | 58,1
63,5
-8,6% | 64,5
63,7
1,2% | 64,9
61,0
6,5% | 77,6
69,8
11% | 77,3
72,4
6,8% | 81,5
78,0
4,5% | 67,0
75,4
-11% | 47,2
49,6
-4,9% | 61,6
55,8
11% |
65,5
|
68,0
|
|
|
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | 40,7
28,3
44% | 38,9
38,4
1,2% | 42,7
42,8
-0,35% | 42,8
39,5
8,2% | 51,4
44,2
16% | 57,8
44,3
30% | 61,6
52,9
16% | 47,3
49,4
-4,3% | 28,5
26,3
8,3% | 42,9
34,2
25% |
43,0
|
44,7
|
47,3
|
55,1
|
62,1
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | 3,32
18,7
-82% | 23,0
29,5
-22% | 25,5
29,8
-15% | 21,8
32,2
-32% | -17,7
37,1
-148% | 45,1
34,1
32% | 37,8
37,5
0,81% | 22,0
30,0
-27% | 7,98
-0,05
15 747% | 55,0
16,3
237% |
22,9
|
23,2
|
24,5
|
31,8
|
34,8
|
Net income
M $ |
Released
Forecast
Spread | -2,82
15,0
-119% | 18,7
19,9
-5,8% | 18,3
23,3
-21% | 20,8
20,1
3,6% | -8,48
22,3
-138% | 37,5
26,9
39% | 29,9
29,1
2,6% | 17,6
25,4
-31% | 10,5
2,58
308% | 48,1
12,0
301% |
22,8
|
26,5
|
|
|
|
EPS
$ |
Released
Forecast
Spread | -0,05
0,28
-118% | 0,35
0,37
-5,4% | 0,35
0,44
-20% | 0,40
0,38
6,0% | -0,17
0,43
-140% | 0,72
0,52
39% | 0,58
0,57
1,8% | 0,34
0,49
-31% | 0,21
0,12
80% | 0,94
0,27
252% |
0,39
|
0,43
|
0,39
|
0,51
|
0,55
| | Announcement Date | 08/07/2018 | 11/06/2018 | 02/05/2019 | 05/07/2019 | 08/06/2019 | 11/01/2019 | 02/04/2020 | 05/05/2020 | 08/04/2020 | 11/04/2020 | | | | | |
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
Previous period
